SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas

Pathology Research and Practice

Volumn 201, Issue 12, 2005, Pages 763-770

  Traub, Frank ^a   Feist, Henning ^a   Kreipe, Hans H ^a   Pich, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Breast cancer; Expression profiling; Mass spectrometry; Proteomics; SELDI

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE;

ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LASER MICRODISSECTION; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; SIGNAL DETECTION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TUMOR DIFFERENTIATION;

EID: 30444451781     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2005.08.011     Document Type: Article

References (22)

1. A.A. Alizadeh D.T. Ross C.M. Perou R.M. Van de Towards a novel classification of human malignancies based on gene expression patterns J. Pathol. 195 2001 41-52
2. K.A. Baggerly J.S. Morris K.R. Coombes Reproducibility of SELDI-TOF protein patterns in serum: Comparing datasets from different experiments Bioinformatics 20 2004 777-785
3. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 7 1976 248-254
4. B. Chakravarthy J.A. Pietenpol Combined modality management of breast cancer: Development of predictive markers through proteomics Semin. Oncol. 30 2003 23-36
5. B.E. Chong R.L. Hamler D.M. Lubman S.P. Ethier A.J. Rosenspire F.R. Miller Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis Anal. Chem. 73 2001 1219-1227
6. E.P. Diamandis Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems J. Natl. Cancer Inst. 96 2004 353-356
7. B. Fisher From Halsted to prevention and beyond: Advances in the management of breast cancer during the twentieth century Eur. J. Cancer 35 1999 1963-1973
8. E. Check Proteomics and cancer: Running before we can walk? Nature 429 2004 496-497
9. H. Hondermarck L. Dolle I. El Yazidi-Belkoura A.S. Vercoutter-Edouart E. Adriaenssens J. Lemoine Functional proteomics of breast cancer for signal pathway profiling and target discovery J. Mammary Gland Biol. Neoplasia 7 2002 395-405
10. J. Li Z. Zhang J. Rosenzweig Y.Y. Wang D.W. Chan Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer Clin. Chem. 48 2002 1296-1304
11. W.H. McDonald J.R. Yates 3rd Shotgun proteomics and biomarker discovery Dis. Markers 18 2002 99-105
12. M. Merchant S.R. Weinberger Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry Electrophoresis 21 2000 1164-1177
13. N. Neuhoff T. Kaiser S. Wittke R. Krebs A. Pitt A. Burchard A. Sundmacher B. Schlegelberger W. Kolch H. Mischak Mass spectrometry for the detection of differentially expressed proteins: A comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry Rapid Commun. Mass Spectrometr. 18 2004 149-156
14. C.M. Perou T. Sorlie M.B. Eisen R.M. van de S.S. Jeffrey C.A. Rees J.R. Pollack D.T. Ross H. Johnsen L.A. Akslen O. Fluge A. Pergamenschikov C. Williams S.X. Zhu P.E. Lonning A.L. Borresen-Dale P.O. Brown D. Botstein Molecular portraits of human breast tumours Nature 406 2000 747-752
15. R. Peto J. Boreham M. Clarke C. Davies V. Beral UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years Lancet 355 2000 1822
16. E.F. Petricoin A.M. Ardekani B.A. Hitt P.J. Levine V.A. Fusaro S.M. Steinberg G.B. Mills C. Simone D.A. Fishman E.C. Kohn L.A. Liotta Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 2002 572-577
17. E.F. Petricoin L.A. Liotta Proteomic approaches in cancer risk and response assessment Trends Mol. Med. 10 2004 59-64
18. M. Schrader P. Schulz-Knappe Peptidomics technologies for human body fluids Trends Biotechnol. 19 2001 55-60
19. J.M. Sorace M. Zhan A data review and re-assessment of ovarian cancer serum proteomic profiling BMC Bioinformatics 4 2003 24
20. J. Stastny R. Prasad E. Fosslien Tissue proteins in breast cancer, as studied by use of two-dimensional electrophoresis Clin. Chem. 30 1984 1198-1914
21. H. Tammen H. Kreipe R. Hess M. Kellmann U. Lehmann A. Pich N. Lamping P. Schulz-Knappe H.D. Zucht R. Lilischkis Expression profiling of breast cancer cells by differential peptide display Breast Cancer Res. Treat. 79 2003 83-93
22. A. Vlahou P.F. Schellhammer S. Mendrinos K. Patel F.I. Kondylis L. Gong S. Nasim J.G. Wright Jr Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine Am. J. Pathol. 158 2001 1491-1502